Centre for Health, Exercise and Sports Medicine, Department of Physiotherapy, School of Health Sciences, Melbourne, Victoria, Australia.
Griffith Centre of Biomedical and Rehabilitation Engineering (GCORE), Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
PLoS One. 2022 Jun 3;17(6):e0257171. doi: 10.1371/journal.pone.0257171. eCollection 2022.
Previous investigations on valgus knee bracing have mostly used the external knee adduction moment. This is a critical limitation, as the external knee adduction moment does not account for muscle forces that contribute substantially to the medial tibiofemoral contact force (MTCF) during walking. The aims of this pilot study were to: 1) determine the effect of a valgus knee brace on MTCF; 2) determine whether the effect is more pronounced after 8 weeks of brace use; 3) assess the feasibility of an 8-week brace intervention.
Participants with medial radiographic knee OA and varus malalignment were fitted with an Össur Unloader One© brace. Participants were instructed to wear the brace for 8 weeks. The MTCF was estimated via an electromyogram-assisted neuromuscular model with and without the knee brace at week 0 and week 8. Feasibility outcomes included change in symptoms, quality of life, confidence, acceptability, adherence and adverse events.
Of the 30 (60% male) participants enrolled, 28 (93%) completed 8-week outcome assessments. There was a main effect of the brace (p<0.001) on peak MTCF and MTCF impulse, but no main effect for time (week 0 and week 8, p = 0.10), and no interaction between brace and time (p = 0.62). Wearing the brace during walking significantly reduced the peak MTCF (-0.05 BW 95%CI [-0.10, -0.01]) and MTCF impulse (-0.07 BW.s 95%CI [-0.09, -0.05]). Symptoms and quality of life improved by clinically relevant magnitudes over the 8-week intervention. Items relating to confidence and acceptability were rated relatively highly. Participants wore the brace on average 6 hrs per day. Seventeen participants reported 30 minor adverse events over an 8-week period.
Although significant, reductions in the peak MTCF and MTCF while wearing the knee brace were small. No effect of time on MTCF was observed. Although there were numerous minor adverse events, feasibility outcomes were generally favourable.
Australian and New Zealand Clinical Trials Registry (12619000622101).
先前关于外翻膝支具的研究大多使用了膝关节外在内收力矩。这是一个关键的局限性,因为膝关节外在内收力矩并未考虑到在行走过程中对胫骨股骨内侧接触力(MTCF)有重要贡献的肌肉力量。本初步研究的目的是:1)确定外翻膝支具对 MTCF 的影响;2)确定在使用支具 8 周后效果是否更加明显;3)评估 8 周支具干预的可行性。
患有内侧放射学膝关节 OA 和内翻畸形的参与者配备了奥索 Unloader One©支具。参与者被指示佩戴支具 8 周。在第 0 周和第 8 周时,使用肌电图辅助的神经肌肉模型在有和没有膝关节支具的情况下估计 MTCF。可行性结果包括症状、生活质量、信心、可接受性、依从性和不良事件的变化。
在 30 名(60%为男性)入组的参与者中,有 28 名(93%)完成了 8 周的结果评估。支具(p<0.001)对峰值 MTCF 和 MTCF 冲量有主要影响,但时间(第 0 周和第 8 周,p=0.10)无主要影响,支具和时间之间无交互作用(p=0.62)。在行走时佩戴支具可显著降低峰值 MTCF(-0.05 BW 95%CI [-0.10,-0.01])和 MTCF 冲量(-0.07 BW.s 95%CI [-0.09,-0.05])。在 8 周的干预过程中,症状和生活质量有临床相关的显著改善。与信心和可接受性相关的项目评分相对较高。参与者平均每天佩戴支具 6 小时。17 名参与者在 8 周内报告了 30 起轻微不良事件。
尽管膝关节支具对峰值 MTCF 和 MTCF 的降低有显著影响,但幅度较小。未观察到时间对 MTCF 的影响。尽管有许多轻微的不良事件,但可行性结果总体上是有利的。
澳大利亚和新西兰临床试验注册(12619000622101)。